Form Type: 4

SEC EDGAR Link
Accession Number:0001209191-20-007481
Date:2020-02-05
Issuer: VERTEX PHARMACEUTICALS INC / MA (VRTX)
Original Submission Date:

Reporting Person:

BOZIC CARMEN
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE BOSTON, MA 02210

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2020-02-05 A 2,098 a $0.00 4,195 direct
COMMON STOCK 2020-02-05 A 10,323 a $0.00 14,518 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
Footnotes
IDfootnote
f1 represents earned performance shares with respect to a performance stock unit award granted on 05/20/2019 that contained performance-vesting requirements. the issuer's management development and compensation committee certified as to the level of performance-goal attainment on 02/05/2020. the earned performance shares will vest in installments beginning on 2/24/2020.
f2 restricted stock unit award that vests in installments beginning on 02/10/2021.
WhaleWisdom Logo

Elevate your investments